Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleDeal watch: Novartis eyes vision-enhancing therapy for macular degeneration.AuthorsCully, MeganAbstractThe article reports on the acquisition of the non-U.S. rights to the aptamer-based therapy for wet age-related macular degeneration (AMD), Fovista, of Ophthotech Corp. by the pharmaceutical company Novartis AG.SubjectsNOVARTIS AG; OPHTHOTECH Corp.PublicationNature Reviews Drug Discovery, 2014, Vol 13, Issue 7, p487ISSN1474-1776Publication typeArticleDOI10.1038/nrd4375